Xuehu Ma

558 citations
7 papers · 408 indexed · 1 hit paper · h-index 5
Topics
Genomics, phytochemicals, and oxidative stress (2 papers)Immunotherapy and Immune Responses (2 papers)Immune Response and Inflammation (2 papers)
Partner nations
ChinaBrazilUnited States

In The Last Decade

Xuehu Ma

6 papers receiving 401 citations

Hit Papers

Vaccine adjuvants: Understanding the structure and mechan...20192026202120232019100200300

Peers

Xuehu Ma
Comparison fields: 5 of 82
  • Immunology 199
  • Molecular Biology 148
  • Infectious Diseases 90
  • Epidemiology 61
  • Materials Chemistry 50
Replace Haoru Zhu with:
Haoru Zhu China
Tingmei Zhao China
Felicity C. Stark Canada
Chelsea L. Bueter United States
Weili Yu China
Chunmiao Hu China
Corinne Cayatte United States
Abbas Jamali Iran
Kadir Turan Türkiye
Panagiota Milona United Kingdom
Xuehu Ma relative to Haoru Zhu China Haoru Zhu's profile →
Citations per field
00.5×3.1×
Haoru Zhu · 1×
Citations per year

Countries citing papers authored by Xuehu Ma

Since Specialization
Citations

This map shows the geographic impact of Xuehu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehu Ma more than expected).

Fields of papers citing papers by Xuehu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehu Ma. The network helps show where Xuehu Ma may publish in the future.

Co-authorship network of co-authors of Xuehu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehu Ma. A scholar is included among the top collaborators of Xuehu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehu Ma. Xuehu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 19
5 44
6
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticitybreakdown →
300
7 40

About Xuehu Ma

Xuehu Ma is a scholar working on Developmental Neuroscience, Endocrinology and Clinical Biochemistry, having authored 7 papers that have together received 408 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (2 papers), Immunotherapy and Immune Responses (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (199 citations), Pharmaceutical Science (31 citations) and Infectious Diseases (90 citations). Xuehu Ma has collaborated with scholars based in China, Brazil and United States. Frequent co-authors include Bingbing Sun, Shuting Shi, Xinyu Xia, Haoru Zhu, Zhihui Liang, Dan Ge, Fang Cheng, Xin Wang, Changying Xue and Min Li. Their work appears in journals such as Nanoscale, Vaccine and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026